AB0765 Quality of life and fatigue in patients with behcet’s disease
Background Behcet’s disease (BD) is a multi-systemic, chronic inflammatory disorder characterized by vasculitis. Fatigue, a common symptom of inflammatory rheumatological disorders such as systemic lupus erythematosus (SLE) and vasculitides, is insufficiently studied in BD. Objectives We aimed to as...
Gespeichert in:
Veröffentlicht in: | Annals of the rheumatic diseases 2013-06, Vol.71 (Suppl 3), p.682-682 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 682 |
---|---|
container_issue | Suppl 3 |
container_start_page | 682 |
container_title | Annals of the rheumatic diseases |
container_volume | 71 |
creator | Can, M. Alibaz-Öner, F. Ilhan, B. Öner, S. Inanc, N. Ergun, T. Mumcu, G. Direskeneli, H. |
description | Background Behcet’s disease (BD) is a multi-systemic, chronic inflammatory disorder characterized by vasculitis. Fatigue, a common symptom of inflammatory rheumatological disorders such as systemic lupus erythematosus (SLE) and vasculitides, is insufficiently studied in BD. Objectives We aimed to assess fatigue in BD, comparing it with other patient-reported outcomes such as disability, quality of life (QoL) and anxiety/depression in this study. Methods Fifty-one patients followed as BD (F/M:32/19, mean age: 39.4 years) fullfilling the International Study Group Criteria (ISG,1990), 24 patients with SLE (F/M:23/1, mean age: 46.5 years) and 31 healthy controls (HC) (F/M: 24/7, mean age: 37.8 years) were enrolled to the study. The clinical activity score in BD was determined by Behcet’s Syndrome Activity Scale (BSAS) and in SLE by SLEDAI. All subjects were asked to complete the Multi-dimensional assessment of fatigue (MAF) questionnaire. SF-36 and hospital anxiety and depression scales were also used to assess QoL together with health assessment questionnaire (HAQ). Results Mean fatigue score was similar among the three groups [22.6 (15.3), 26.6 (10.9) and 24.1 (11.8) in BD, SLE and HC respectively] (p=0.4). When BD patients were separately analysed in 2 groups (mucocutaneous (MC) (n=17) and major organ involvement (MO) (ocular, vascular and central nervous system) (n=21)), fatigue score was also not different among both groups [22.3(17.7) vs 21.2(17.0), MC and MO respectively]. However, BSAS score was observed to correlate with the fatigue score (r=0.5, p=0.001).HAQ scores were impaired in BD and SLE patients compared to HC [0.32(0.42), 0.42(0.36) and 0.07 (0.1), respectively] (p0.05), and depression scores were similar [6.3 (4.1), 7.2 (3.1) and 5.8 (3.5) in BD, SLE and HC respectively] (p>0.05) among the 3 groups. In subgroup analysis, SF-36 mental and physical components, depression and anxiety scores and HAQ were also not different between MC and MO groups. Conclusions Contrary to previous studies, in this hospital-based, observational cohort study, fatigue seems to be similar in magnitude in BD compared to SLE and HC. Although major organ involvement did not affect fatigue severity, an association of fatigue with disease activity is observed. Disclosure of Interest None Declared |
doi_str_mv | 10.1136/annrheumdis-2012-eular.765 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1777977093</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4008638121</sourcerecordid><originalsourceid>FETCH-LOGICAL-b1633-46af0cadfabe6c7e4c2f43dad72799831ab6f7b46957da6d95b5e1ed3e28f9823</originalsourceid><addsrcrecordid>eNqVkEtOwzAURS0EEqWwBwvGKXac2DGzfoAiVUVI0KnlJM80JU2LnQg664RFsL2uBJcgxJSRPzr33aeD0DklPUoZv9RVZefQLPPCBSGhYQBNqW1P8PgAdWjEE__LySHqEEJYEEkujtGJcwv_JAlNOmjcHxBP77YfD40ui3qDVwaXhQGsqxwbXRfPDeCiwmt_hap2-K2o5ziFeQb1bvvpsK8G7eAUHRldOjj7Obvo6eb6cTgOJve3d8P-JEgpZ34Frg3JdG50CjwTEGWhiViucxEKKRNGdcqNSCMuY5Frnss4jYFCziBMjExC1kUX7dy1Xb024Gq1WDW28pWKCiGkEEQyT121VGZXzlkwam2LpbYbRYnam1N_zKm9OfVtTnkXPhy04cLV8P6b1PZFccFErKazoZoOZmE8kkKNPB-3fLpc_KfnC_1kijM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1777977093</pqid></control><display><type>article</type><title>AB0765 Quality of life and fatigue in patients with behcet’s disease</title><source>BMJ Journals - NESLi2</source><creator>Can, M. ; Alibaz-Öner, F. ; Ilhan, B. ; Öner, S. ; Inanc, N. ; Ergun, T. ; Mumcu, G. ; Direskeneli, H.</creator><creatorcontrib>Can, M. ; Alibaz-Öner, F. ; Ilhan, B. ; Öner, S. ; Inanc, N. ; Ergun, T. ; Mumcu, G. ; Direskeneli, H.</creatorcontrib><description>Background Behcet’s disease (BD) is a multi-systemic, chronic inflammatory disorder characterized by vasculitis. Fatigue, a common symptom of inflammatory rheumatological disorders such as systemic lupus erythematosus (SLE) and vasculitides, is insufficiently studied in BD. Objectives We aimed to assess fatigue in BD, comparing it with other patient-reported outcomes such as disability, quality of life (QoL) and anxiety/depression in this study. Methods Fifty-one patients followed as BD (F/M:32/19, mean age: 39.4 years) fullfilling the International Study Group Criteria (ISG,1990), 24 patients with SLE (F/M:23/1, mean age: 46.5 years) and 31 healthy controls (HC) (F/M: 24/7, mean age: 37.8 years) were enrolled to the study. The clinical activity score in BD was determined by Behcet’s Syndrome Activity Scale (BSAS) and in SLE by SLEDAI. All subjects were asked to complete the Multi-dimensional assessment of fatigue (MAF) questionnaire. SF-36 and hospital anxiety and depression scales were also used to assess QoL together with health assessment questionnaire (HAQ). Results Mean fatigue score was similar among the three groups [22.6 (15.3), 26.6 (10.9) and 24.1 (11.8) in BD, SLE and HC respectively] (p=0.4). When BD patients were separately analysed in 2 groups (mucocutaneous (MC) (n=17) and major organ involvement (MO) (ocular, vascular and central nervous system) (n=21)), fatigue score was also not different among both groups [22.3(17.7) vs 21.2(17.0), MC and MO respectively]. However, BSAS score was observed to correlate with the fatigue score (r=0.5, p=0.001).HAQ scores were impaired in BD and SLE patients compared to HC [0.32(0.42), 0.42(0.36) and 0.07 (0.1), respectively] (p<0.01). Anxiety [6.6 (4.2), 7.5 (4.1) and 6.0 (4.6) in BD, SLE and HC, respectively) (p>0.05), and depression scores were similar [6.3 (4.1), 7.2 (3.1) and 5.8 (3.5) in BD, SLE and HC respectively] (p>0.05) among the 3 groups. In subgroup analysis, SF-36 mental and physical components, depression and anxiety scores and HAQ were also not different between MC and MO groups. Conclusions Contrary to previous studies, in this hospital-based, observational cohort study, fatigue seems to be similar in magnitude in BD compared to SLE and HC. Although major organ involvement did not affect fatigue severity, an association of fatigue with disease activity is observed. Disclosure of Interest None Declared</description><identifier>ISSN: 0003-4967</identifier><identifier>EISSN: 1468-2060</identifier><identifier>DOI: 10.1136/annrheumdis-2012-eular.765</identifier><identifier>CODEN: ARDIAO</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and European League Against Rheumatism</publisher><ispartof>Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.682-682</ispartof><rights>2013, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><rights>Copyright: 2013 (c) 2013, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://ard.bmj.com/content/71/Suppl_3/682.6.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://ard.bmj.com/content/71/Suppl_3/682.6.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,314,780,784,3196,23571,27924,27925,77600,77631</link.rule.ids></links><search><creatorcontrib>Can, M.</creatorcontrib><creatorcontrib>Alibaz-Öner, F.</creatorcontrib><creatorcontrib>Ilhan, B.</creatorcontrib><creatorcontrib>Öner, S.</creatorcontrib><creatorcontrib>Inanc, N.</creatorcontrib><creatorcontrib>Ergun, T.</creatorcontrib><creatorcontrib>Mumcu, G.</creatorcontrib><creatorcontrib>Direskeneli, H.</creatorcontrib><title>AB0765 Quality of life and fatigue in patients with behcet’s disease</title><title>Annals of the rheumatic diseases</title><addtitle>Ann Rheum Dis</addtitle><description>Background Behcet’s disease (BD) is a multi-systemic, chronic inflammatory disorder characterized by vasculitis. Fatigue, a common symptom of inflammatory rheumatological disorders such as systemic lupus erythematosus (SLE) and vasculitides, is insufficiently studied in BD. Objectives We aimed to assess fatigue in BD, comparing it with other patient-reported outcomes such as disability, quality of life (QoL) and anxiety/depression in this study. Methods Fifty-one patients followed as BD (F/M:32/19, mean age: 39.4 years) fullfilling the International Study Group Criteria (ISG,1990), 24 patients with SLE (F/M:23/1, mean age: 46.5 years) and 31 healthy controls (HC) (F/M: 24/7, mean age: 37.8 years) were enrolled to the study. The clinical activity score in BD was determined by Behcet’s Syndrome Activity Scale (BSAS) and in SLE by SLEDAI. All subjects were asked to complete the Multi-dimensional assessment of fatigue (MAF) questionnaire. SF-36 and hospital anxiety and depression scales were also used to assess QoL together with health assessment questionnaire (HAQ). Results Mean fatigue score was similar among the three groups [22.6 (15.3), 26.6 (10.9) and 24.1 (11.8) in BD, SLE and HC respectively] (p=0.4). When BD patients were separately analysed in 2 groups (mucocutaneous (MC) (n=17) and major organ involvement (MO) (ocular, vascular and central nervous system) (n=21)), fatigue score was also not different among both groups [22.3(17.7) vs 21.2(17.0), MC and MO respectively]. However, BSAS score was observed to correlate with the fatigue score (r=0.5, p=0.001).HAQ scores were impaired in BD and SLE patients compared to HC [0.32(0.42), 0.42(0.36) and 0.07 (0.1), respectively] (p<0.01). Anxiety [6.6 (4.2), 7.5 (4.1) and 6.0 (4.6) in BD, SLE and HC, respectively) (p>0.05), and depression scores were similar [6.3 (4.1), 7.2 (3.1) and 5.8 (3.5) in BD, SLE and HC respectively] (p>0.05) among the 3 groups. In subgroup analysis, SF-36 mental and physical components, depression and anxiety scores and HAQ were also not different between MC and MO groups. Conclusions Contrary to previous studies, in this hospital-based, observational cohort study, fatigue seems to be similar in magnitude in BD compared to SLE and HC. Although major organ involvement did not affect fatigue severity, an association of fatigue with disease activity is observed. Disclosure of Interest None Declared</description><issn>0003-4967</issn><issn>1468-2060</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqVkEtOwzAURS0EEqWwBwvGKXac2DGzfoAiVUVI0KnlJM80JU2LnQg664RFsL2uBJcgxJSRPzr33aeD0DklPUoZv9RVZefQLPPCBSGhYQBNqW1P8PgAdWjEE__LySHqEEJYEEkujtGJcwv_JAlNOmjcHxBP77YfD40ui3qDVwaXhQGsqxwbXRfPDeCiwmt_hap2-K2o5ziFeQb1bvvpsK8G7eAUHRldOjj7Obvo6eb6cTgOJve3d8P-JEgpZ34Frg3JdG50CjwTEGWhiViucxEKKRNGdcqNSCMuY5Frnss4jYFCziBMjExC1kUX7dy1Xb024Gq1WDW28pWKCiGkEEQyT121VGZXzlkwam2LpbYbRYnam1N_zKm9OfVtTnkXPhy04cLV8P6b1PZFccFErKazoZoOZmE8kkKNPB-3fLpc_KfnC_1kijM</recordid><startdate>201306</startdate><enddate>201306</enddate><creator>Can, M.</creator><creator>Alibaz-Öner, F.</creator><creator>Ilhan, B.</creator><creator>Öner, S.</creator><creator>Inanc, N.</creator><creator>Ergun, T.</creator><creator>Mumcu, G.</creator><creator>Direskeneli, H.</creator><general>BMJ Publishing Group Ltd and European League Against Rheumatism</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope></search><sort><creationdate>201306</creationdate><title>AB0765 Quality of life and fatigue in patients with behcet’s disease</title><author>Can, M. ; Alibaz-Öner, F. ; Ilhan, B. ; Öner, S. ; Inanc, N. ; Ergun, T. ; Mumcu, G. ; Direskeneli, H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b1633-46af0cadfabe6c7e4c2f43dad72799831ab6f7b46957da6d95b5e1ed3e28f9823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Can, M.</creatorcontrib><creatorcontrib>Alibaz-Öner, F.</creatorcontrib><creatorcontrib>Ilhan, B.</creatorcontrib><creatorcontrib>Öner, S.</creatorcontrib><creatorcontrib>Inanc, N.</creatorcontrib><creatorcontrib>Ergun, T.</creatorcontrib><creatorcontrib>Mumcu, G.</creatorcontrib><creatorcontrib>Direskeneli, H.</creatorcontrib><collection>Istex</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><jtitle>Annals of the rheumatic diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Can, M.</au><au>Alibaz-Öner, F.</au><au>Ilhan, B.</au><au>Öner, S.</au><au>Inanc, N.</au><au>Ergun, T.</au><au>Mumcu, G.</au><au>Direskeneli, H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>AB0765 Quality of life and fatigue in patients with behcet’s disease</atitle><jtitle>Annals of the rheumatic diseases</jtitle><addtitle>Ann Rheum Dis</addtitle><date>2013-06</date><risdate>2013</risdate><volume>71</volume><issue>Suppl 3</issue><spage>682</spage><epage>682</epage><pages>682-682</pages><issn>0003-4967</issn><eissn>1468-2060</eissn><coden>ARDIAO</coden><abstract>Background Behcet’s disease (BD) is a multi-systemic, chronic inflammatory disorder characterized by vasculitis. Fatigue, a common symptom of inflammatory rheumatological disorders such as systemic lupus erythematosus (SLE) and vasculitides, is insufficiently studied in BD. Objectives We aimed to assess fatigue in BD, comparing it with other patient-reported outcomes such as disability, quality of life (QoL) and anxiety/depression in this study. Methods Fifty-one patients followed as BD (F/M:32/19, mean age: 39.4 years) fullfilling the International Study Group Criteria (ISG,1990), 24 patients with SLE (F/M:23/1, mean age: 46.5 years) and 31 healthy controls (HC) (F/M: 24/7, mean age: 37.8 years) were enrolled to the study. The clinical activity score in BD was determined by Behcet’s Syndrome Activity Scale (BSAS) and in SLE by SLEDAI. All subjects were asked to complete the Multi-dimensional assessment of fatigue (MAF) questionnaire. SF-36 and hospital anxiety and depression scales were also used to assess QoL together with health assessment questionnaire (HAQ). Results Mean fatigue score was similar among the three groups [22.6 (15.3), 26.6 (10.9) and 24.1 (11.8) in BD, SLE and HC respectively] (p=0.4). When BD patients were separately analysed in 2 groups (mucocutaneous (MC) (n=17) and major organ involvement (MO) (ocular, vascular and central nervous system) (n=21)), fatigue score was also not different among both groups [22.3(17.7) vs 21.2(17.0), MC and MO respectively]. However, BSAS score was observed to correlate with the fatigue score (r=0.5, p=0.001).HAQ scores were impaired in BD and SLE patients compared to HC [0.32(0.42), 0.42(0.36) and 0.07 (0.1), respectively] (p<0.01). Anxiety [6.6 (4.2), 7.5 (4.1) and 6.0 (4.6) in BD, SLE and HC, respectively) (p>0.05), and depression scores were similar [6.3 (4.1), 7.2 (3.1) and 5.8 (3.5) in BD, SLE and HC respectively] (p>0.05) among the 3 groups. In subgroup analysis, SF-36 mental and physical components, depression and anxiety scores and HAQ were also not different between MC and MO groups. Conclusions Contrary to previous studies, in this hospital-based, observational cohort study, fatigue seems to be similar in magnitude in BD compared to SLE and HC. Although major organ involvement did not affect fatigue severity, an association of fatigue with disease activity is observed. Disclosure of Interest None Declared</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and European League Against Rheumatism</pub><doi>10.1136/annrheumdis-2012-eular.765</doi><tpages>1</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0003-4967 |
ispartof | Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.682-682 |
issn | 0003-4967 1468-2060 |
language | eng |
recordid | cdi_proquest_journals_1777977093 |
source | BMJ Journals - NESLi2 |
title | AB0765 Quality of life and fatigue in patients with behcet’s disease |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T10%3A53%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=AB0765%E2%80%85Quality%20of%20life%20and%20fatigue%20in%20patients%20with%20behcet%E2%80%99s%20disease&rft.jtitle=Annals%20of%20the%20rheumatic%20diseases&rft.au=Can,%20M.&rft.date=2013-06&rft.volume=71&rft.issue=Suppl%203&rft.spage=682&rft.epage=682&rft.pages=682-682&rft.issn=0003-4967&rft.eissn=1468-2060&rft.coden=ARDIAO&rft_id=info:doi/10.1136/annrheumdis-2012-eular.765&rft_dat=%3Cproquest_cross%3E4008638121%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1777977093&rft_id=info:pmid/&rfr_iscdi=true |